Abstract
We sought to compare the combination therapy of adenosine and nitroprusside in no-reflow phenomenon during percutaneous coronary intervention. Improvement in coronary flow from no-reflow to postdrug state was evaluated. Patients who received adenosine (n = 21) were compared to ones who received the combination of adenosine and nitroprusside (n = 20) for treatment. Improvement of TIMI flow grades was higher in the group that received combined therapy (1.5 ± 1.0 vs. 0.8 ± 0.6; P < 0.05). Combination therapy of adenosine and nitroprusside is safe and provides better improvement in coronary flow compared to intracoronary adenosine alone in case of impaired flow during coronary interventions.
Original language | English (US) |
---|---|
Pages (from-to) | 484-491 |
Number of pages | 8 |
Journal | Catheterization and Cardiovascular Interventions |
Volume | 61 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2004 |
Keywords
- Adenosine
- Coronary
- Coronary blood flow
- Percutaneous coronary intervention
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine